Primary Types of Cancer
Cancer is classified into several major types based on tissue origin, with the most common being carcinomas (epithelial origin), sarcomas (bone and soft tissue), leukemias (blood), lymphomas (lymphatic system), and central nervous system cancers. 1
Bone Cancers
Bone cancers are rare malignancies accounting for less than 0.2% of all cancers but have significant impact on morbidity and mortality 2. The main types include:
Osteosarcoma
- Most common primary bone cancer (35% of bone cancers), with highest incidence in adolescents and a second peak in the elderly 2
- Typically arises in the metaphysis of long bones, particularly around the knee (distal femur, proximal tibia) 2
- Male-to-female ratio is 1.4:1 2
- Risk factors include previous radiation therapy, Paget's disease, and genetic syndromes (Li-Fraumeni, Werner, Rothmund-Thomson) 2
- Subtypes include conventional (80-90%), which can be osteoblastic, chondroblastic, or fibroblastic; and rarer variants like telangiectatic, small cell, and surface osteosarcomas 2
Ewing Sarcoma
- Second most common bone cancer (16% of bone cancers), primarily affecting children and adolescents 2
- Median age at diagnosis is 15 years with male predominance (1.5:1) 2
- More common in white Caucasians and rare in African and Asian populations 2
- Approximately 25% occur in pelvic bones, 50% in extremities, with ribs and vertebral column also frequently affected 2
- Can arise in both bone and soft tissues 2
Chondrosarcoma
- Accounts for approximately 30% of bone cancers, most common in adults aged 30-60 years 2
- Equal gender distribution 2
- Most arise as primary malignant tumors, with majority being low-grade (grade I) 2
- Typically develops in the diametaphyseal region of long bones, pelvis, ribs, and scapula 2
Other Bone Cancers
- Undifferentiated pleomorphic sarcoma (previously called malignant fibrous histiocytoma) - typically high-grade with metastatic rates of at least 50% 2
- Chordoma - rare tumor arising from notochordal remnants, primarily affecting the sacrum (50%), skull base (30%), and mobile spine (20%) 2
- Giant cell tumor of bone - has both benign and malignant potential 2
- Round cell sarcomas with EWSR1:non-ETS fusions - newly defined entities previously called Ewing-like sarcomas 2
Carcinomas
Carcinomas are malignancies arising from epithelial cells that line organs or tissues 3:
- Most common type of cancer overall
- Defined by breach of basement membrane by proliferating epithelial cells 3
- Major types include:
Leukemias
- Cancers of blood-forming tissues, primarily affecting white blood cells 4
- Characterized by abnormal proliferation of immature blood cells in bone marrow
- Major types include acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), and chronic myeloid leukemia (CML)
Risk Factors and Epidemiology
- Cancer incidence increases exponentially with age in adults 1
- Major modifiable risk factors include tobacco use, excess alcohol consumption, obesity, physical inactivity, poor diet, infectious agents, and sun exposure 1
- Marked international variation exists in cancer incidence 1
Clinical Considerations
- Early detection significantly improves survival rates for many cancers including breast, cervical, colorectal, lung, and prostate 1
- Timely diagnosis of bone cancers is challenging due to nonspecific symptoms that mimic musculoskeletal injuries 4
- Plain radiography is the preferred initial diagnostic test for bone cancers 4
- Treatment typically involves multidisciplinary care at specialized cancer centers 2, 4
- For bone cancers like osteosarcoma and Ewing sarcoma, neoadjuvant and adjuvant chemotherapy combined with surgery has improved survival rates to nearly 80% for localized disease 4
Advances in Cancer Management
- Molecular characterization of cancers is increasingly important for diagnosis and treatment planning 5
- Technological advances allow detailed analysis of cancer types, leading to more precise diagnostics and targeted therapies 5
- The goal of modern cancer care is to provide individualized therapeutic regimens tailored to each patient's specific disease 5